Galt Pharmaceuticals
Franchise Information
Analyzed filing: MN · File #987820287
Filed: Sep 1, 2026
FDD Issued: Apr 6, 2026
Extracted: Sep 6, 2026
Analyzed
Franchisor Details
Galt Phranchise Systems, LLC
Galt Companies, LLC
3350 Riverwood Parkway, Suite 1900, Atlanta, Georgia 30339
855-965-2783
2018
Industry & Qualifications
Health & Medical
$100,000 - $300,000
Not disclosed
$122K - $349K
5 years
Renewable
Outlet Information
63
63
+14
-20
Churn Breakdown (Last Year)
0
0
20
1
0
Disclosed
24 Operational Franchise Outlets with 53 territories open the entire 2025 Report...
Financial Performance (Item 19)
$338,618
$45,031
$2,055,300
24 units
Legal History
None
None
| Number | File name | Source State | Filing Date | Actions |
|---|---|---|---|---|
| 1624870392 |
MN_36868-202606-11_galt-phranchise-systems,-llc.pdf
Alternate source copy
· newest filing
|
MN | Sep 1, 2026 | |
| 987820287 |
MN_36868-202606-03_galt-phranchise-systems,-llc.pdf
Canonical 2026 analysis
|
MN | Sep 1, 2026 | |
| 805133993 |
MN_36868-202606-10_galt-phranchise-systems,-llc.pdf
Alternate source copy
|
MN | Sep 1, 2026 | |
| 4755 |
CA_APP00004755.pdf
Alternate source copy
|
CA | Jul 21, 2026 | |
| 2204 |
CA_APP00002204.pdf
Alternate source copy
|
CA | Jul 17, 2026 | |
| 254567 |
487839_Franchise__Galt_Pharmaceuticals_EFDID__4_New York_254567.pdf
Alternate source copy
|
NY | Apr 23, 2025 | |
| 235013 |
487839_Franchise__Galt_Pharmaceuticals_EFDID__4_Illinois_235013.pdf
Alternate source copy
|
IL | Apr 23, 2025 | |
| 263298 |
487839_Franchise__Galt_Pharmaceuticals_EFDID__4_Virginia_263298.pdf
Canonical 2025 analysis
|
VA | Apr 23, 2025 | |
| 166824 |
487839_Franchise__Galt_Pharmaceuticals_EFDID__4_New York_166824.pdf
Canonical 2024 analysis
|
NY | Apr 29, 2024 | |
| 104251 |
487839_Franchise__Galt_Pharmaceuticals_EFDID__4_New York_104251.pdf
Canonical 2023 analysis
|
NY | May 9, 2023 |
Prev
Page 1 of 1
Next